Skip to main content
$4.99 $0.02 (0.4%)

04:00 PM EDT on 05/20/22

Co-Diagnostics, Inc. (NASDAQ:CODX)

CAPS Rating: 1 out of 5

Current Price $4.99 Mkt Cap $169.6M
Open $5.06 P/E Ratio 3.72
Prev. Close $4.99 Div. (Yield) $0.00 (0.0%)
Daily Range $4.90 - $5.20 Volume 211,003
52-Wk Range $3.66 - $11.82 Avg. Daily Vol. 289,595

Caps

How do you think NASDAQ:CODX will perform against the market?

Add Stock to CAPS Watchlist

All Players

37 Outperform
38 Underperform
 

All-Star Players

6 Outperform
29 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CODX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

peacemaker01 (60.45)
Submitted April 19, 2020

CODX is a frontrunner in diagnostic tests for covid19.

joaquingrech (98.33)
Submitted March 27, 2020

it may surge now but long term i just don't see it, only 1 product and easy to replicate

NASDAQ:CODX VS S&P 500 (SPY)

NASDAQ:CODX Summary

Fools bullish on NASDAQ:CODX are also bullish on:

Fools bearish on NASDAQ:CODX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CODX.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 5/13/2021 5:42:16 PM : Outperform Start Price: $7.49 NASDAQ:CODX Score: -22.03

Tiny $200M market cap biotech that is already profitable. No debt and 50% margins. Has patented co-primer technology that works with both DNA and RNA. Approx. 50% International sales of Covid 19 PCR test. Pursuing a broad range of clinical testing possibilities including liquid biopsy cancer detection and direct to consumer Covid testing.

Recs

0
Member Avatar Kentuckyfarmer (< 20) Submitted: 1/15/2021 7:22:08 AM : Outperform Start Price: $10.13 NASDAQ:CODX Score: -53.50

Increased revenue in 2020 was due to covid-19 testing and that was just what the company needed to finally become profitable. They have many other test capabilities if Covid-19 tests go away. They are also involved in the agricultural field which is another interesting avenue for growth in the future. Small cap with lots of room to run

Recs

0
Member Avatar TMFbonefish (34.30) Submitted: 1/12/2021 7:09:04 PM : Outperform Start Price: $10.42 NASDAQ:CODX Score: -54.33

Intellectual property that results in better product performance in a fast-growing competitive space is a recipe for getting acquired or being in a position to take share from others. Applications in agriculture are also intriguing.

Leaderboard

Find the members with the highest scoring picks in CODX.

Score Leader

copetom

copetom (42.88) Score: +426.68

Due to the panic over covid-19 I marked it as outperform. Which it did for a few days. I have since sold it, NVAX, INO, and 2 others. Nice profit on NVAX especially.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Toprope101 99.89 3/12/2020 Underperform 5Y $12.76 -60.74% +51.51% +112.25 0 Comment
RayNobleEsq 99.97 4/21/2020 Underperform 5Y $13.46 -62.78% +41.12% +103.90 0 Comment
Halffrenzy 25.91 5/20/2020 Underperform 5Y $18.43 -72.82% +30.26% +103.07 0 Comment
NorteClub 89.02 7/29/2020 Underperform 5Y $22.14 -77.37% +20.41% +97.78 0 Comment
joaquingrech 98.33 3/27/2020 Underperform 5Y $9.19 -45.48% +51.77% +97.25 1 Comment
dinasourneil 99.59 3/6/2020 Underperform 1Y $14.23 -64.79% +32.38% +97.17 0 Comment
OklaBoston 58.52 1/29/2020 Outperform 3Y $2.34 +114.10% +18.35% +95.75 2 Comments
cvdynasty0 99.93 4/16/2020 Underperform 5Y $11.28 -55.59% +39.88% +95.47 0 Comment
chrispycrunch 91.44 3/5/2020 Underperform 5Y $14.65 -65.80% +27.32% +93.13 0 Comment
ClientNein 100.00 7/17/2020 Underperform 5Y $17.75 -71.77% +20.51% +92.29 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CODX.